These results indicate that EspF may target the nucleus, impair ribosome biogenesis to inhibit translation and protein synthesis to deplete repair proteins, and promote cell cycle arrest or apoptosis activated by p53 (37, 53, 54), which, alongside the differential gene analysis results (Fig. 2H), supports its relevance to cancer. The gene discussed is TP53; the disease is cancer.